openPR Logo
Press release

Traumatic Brain Injury (TBI) - Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | AivoCode LLP, AlphaCognition Inc, ALSP Inc, AlzeCure Pharma AB

12-18-2023 08:09 PM CET | Health & Medicine

Press release from: Global Insight Services

Traumatic Brain Injury (TBI) - Pipeline Assessment, 2023

As per Global Insight services' assessment, about 60+ prominent pharma and biotech giants are working on 60+ drugs in the Traumatic Brain Injury (TBI) - pipeline landscape globally. Traumatic Brain Injury (TBI) Pipeline Insight, 2023" report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.

Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies : https://www.globalinsightservices.com/request-sample/GIS31128/?utm_source=sidram&utm_medium=linkewire&utm_campaign=18122023

Traumatic Brain Injury (TBI) is a disruption in the normal function of the brain that can be caused by a blow, bump or jolt to the head, the head suddenly and violently hitting an object or when an object pierces the skull and enters brain tissue. Traumatic brain injury is the leading cause of death and disability worldwide and, can be fatal especially in children and adolescents.

The most common cause of traumatic brain injury (TBI) is traffic accidents, which are mostly obstructive and are accompanied by physical or neurological disorders caused by multiple or local injuries and caused by external impact caused by coup injury that occurs on the part hitting an object and contrecoup injury that occurs on the other side due to acceleration.

Read more about Traumatic Brain Injury (TBI) Pipeline Insight here: https://www.globalinsightservices.com/reports/traumatic-brain-injury-tbi-drug-pipeline-landscape//?utm_source=sidram&utm_medium=linkewire&utm_campaign=18122023

Report Highlights

Global Insight Service's, Traumatic Brain Injury (TBI) - Drug Pipeline Landscape, 2023 report provides an overview of the Traumatic Brain Injury (TBI) pipeline drugs. This report covers detailed insights on Traumatic Brain Injury (TBI) drugs under development, assessment by target, mechanism of action, route of administration and molecule type.Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Traumatic Brain Injury (TBI) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Key Players

• AivoCode LLP
• AlphaCognition Inc
• ALSP Inc
• AlzeCure Pharma AB
• Anagin Inc
• Angion Biomedica Corp
• Annovis Bio Inc
• AntiRadical Therapeutics LLC
• Astrocyte Pharmaceuticals Inc
• Athersys Inc
• Avanir Pharmaceuticals Inc
• B Cell Solutions Inc

For In-Depth Competitive Analysis, Purchase this Report : https://www.globalinsightservices.com/checkout/single_user/GIS31128/?utm_source=sidram&utm_medium=linkewire&utm_campaign=18122023

Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -

- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail:info@globalinsightservices.com
Phone: +1-833-761-1700
Website:https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Traumatic Brain Injury (TBI) - Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | AivoCode LLP, AlphaCognition Inc, ALSP Inc, AlzeCure Pharma AB here

News-ID: 3331323 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for Traumatic

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Traumatic Brain Injury Assessment and Management Devices Market - Breakthrough t …
Newark, New Castle, USA: The "Traumatic Brain Injury Assessment and Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Traumatic Brain Injury Assessment and Management Devices
The increase in the prevalence of brain traumatic injuries is projected to boost …
The research report "Traumatic Brain Injury Treatment Market: By Treatment Type (Drugs, Surgery), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography - Global/Region/Country Forecast to 2028. The traumatic brain injury treatment market size was valued at USD 3.03 billion in 2021 is and anticipated to grow at 8.2% CAGR rate over the forecast period 2022-2028. Glance our 200 slides market research and
Global Traumatic Brain Injury Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Traumatic Brain Injury Market is projected to grow from USD 3.1 billion in 2021 to USD 4.5 billion by 2026 at CAGR of 8.0%. The increasing prevalence of traumatic brain injuries (TBIs), rising preference for minimally invasive procedures, and increasing awareness regarding early diagnosis of brain injuries are the major factors expected to fuel the market
Traumatic Acid Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Traumatic Acid analysis, which studies the Traumatic Acid industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Traumatic Acid Market 2020-2025” Research Report categorizes the global Traumatic Acid by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth rate, opportunities
Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018 - ResearchByMa …
"Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018", provides an overview of the Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) pipeline landscape. Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others with a history of repetitive brain trauma. Symptoms include loss of consciousness, headache, drowsiness, convulsions and slurred speech, nausea or vomiting and unusual behavior. Risk factors include repeated exposure to traumatic brain